← Back to Search

Phototherapy

Luma Light Therapy for Psoriasis

N/A

Waitlist Available

Research Sponsored by Illumicure Inc

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Target plaque assessment (TPA) score between 6-9 and a score of at least 2 for each of the 3 different psoriasis signs and symptoms (erythema, plaque elevation, and scaling)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial will compare the effectiveness of a new treatment for psoriasis (a combination of light therapy and an occlusive dressing) to light therapy alone and to no treatment, in 10 patients.

Who is the study for?

Adults aged 18-65 with mild to moderate psoriasis, who have specific scores on plaque assessments and are in good health. Women must agree to use contraception and not be pregnant or nursing. Participants can't join if they have skin conditions that could affect results, were non-responsive to previous psoriasis treatments, or recently took part in other drug/device trials.Check my eligibility

What is being tested?

The study is testing the Luma Light System's effectiveness when combined with an occlusive dressing versus using the light or dressing alone, as well as no treatment at all. This six-week trial involves ten patients divided into four groups to compare these methods for treating psoriasis.See study design

What are the potential side effects?

While specific side effects are not listed for this proof of concept study, potential risks may include skin irritation from the light system or occlusive dressing and reactions related to UV exposure such as burning or increased pigmentation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My psoriasis is moderate with noticeable redness, thickness, and scaling.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Local Skin Reactions

Target Plaque Assessment

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Luma Light SystemExperimental Treatment1 Intervention

The experimental arm will be a combination of an occlusive dressing and NBUVB light.

Group II: Non-treatment ControlActive Control1 Intervention

Control arm will not have any intervention

Group III: Occlusive DressingActive Control1 Intervention

An off-the-shelf dressing occlusive dressing will be used as an active comparator.

Group IV: Luma LightActive Control1 Intervention

A NBUVB light will be used as an active comparator.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Illumicure IncLead Sponsor

1 Previous Clinical Trials

32 Total Patients Enrolled

1 Trials studying Psoriasis

32 Patients Enrolled for Psoriasis

Media Library

Luma Light System (Phototherapy) Clinical Trial Eligibility Overview. Trial Name: NCT02447068 — N/A

Psoriasis Research Study Groups: Non-treatment Control, Occlusive Dressing, Luma Light, Luma Light System

Psoriasis Clinical Trial 2023: Luma Light System Highlights & Side Effects. Trial Name: NCT02447068 — N/A

Luma Light System (Phototherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02447068 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I be considered a viable candidate for this research trial?

"This clinical trial is accepting 10 candidates, who must fit the following criteria: adult of any gender and race between 18-65 years old; mild to moderate psoriasis with TPA scores 6-9 inclusive at baseline visits and 2 for erythema, plaque elevation, and scaling; 4 plaques measuring ≥10 cm2 where no two differ by more than 1 score; general good health according to medical history & examination. Additionally, females of childbearing potential are obliged to utilize reliable contraceptive methods from screening until 30 days after treatment ends. The study requires participants use only Sponsor provided hygiene products during the trial period. Lastly, an"

Answered by AI

Is the age requirement for this trial limited to individuals above 50 years old?

"In accordance with the stated admission qualifications, participants need to be between 18 and 65 years of age in order to take part."

Answered by AI

Are there any remaining opportunities for participants in this trial?

"The information on clinicaltrials.gov points to this trial not currently recruiting individuals, despite first being posted in May of 2015 and lastly updated three weeks later. While no participants are being sought at the current moment, 168 other medical studies are actively seeking enrollees."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis

2015. "Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02447068.

All > Psoriasis > Plaque Psoriasis